# K143590: Alevicyn SG Antipruritic Gel

- Pathway: 510(k) (Traditional)
- Applicant: Oculus Innovative Sciences
- Decided: Jun 4, 2015 after 168 days
- Product code: FRO (Dressing, Wound, Drug)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K830708 (1983). 16 ancestors in all.
4 later devices descend from it; 1 cites it directly.
0 of 21 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K102945: Pediacyn Atopic Dermatitis Hydrogel, Oculus Innovative Sciences, Inc. (2011) Summary page 4.

## Most influential descendants
- K152945: Alevicyn SG Antipruritic Gel (2015), 3 descendants of its own
- K171935: Alevicyn SG Antimicrobial Gel (2017), 1 descendant of its own
- K173896: Microcyn Antimicrobial Hydrogel (2018), 0 descendants of its own
- K162217: LOYON (2017), 0 descendants of its own

## Indications for use
Rx: Rx Indication: Alevicyn SG Antipruritic Gel is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including radiation dermatitis and atopic dermatitis. Alevicyn SG Antipruritic Gel may be also used to relieve the pain of first and second degree burns. Alevicyn SG Antipruritic Gel helps to relieve dry waxy skin by maintaining a moist wound & skin environment, which is beneficial to the healing process. OTC Indication: Alevicyn SG Antipruritic Gel is intended to relieve the burning and itching associated with many common types of skin irritation, lacerations, abrasions, and minor burns. Alevicyn SG Antipruritic Gel is also indicated for the management of irritation and pain from minor burns, including sunburn.

Source page: https://510kreport.com/device/K143590
Methodology: https://510kreport.com/methodology